Paper25757620
Vector-mediated antibody gene transfer for infectious diseases.
Schnepp BC and 1 other. Adv Exp Med Biol, 2015. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Vector-mediated antibody gene transfer for infectious diseases. Papers, record 25757620. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25757620
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Neutralizing | Major topic |
| Communicable Diseases | Major topic |
| Gene Transfer Techniques | Major topic |
| Genes, Immunoglobulin | Major topic |
| Genetic Vectors | Major topic |
| Animals | |
| Antibodies, Monoclonal | |
| HIV Antibodies | |
| HIV Infections | |
| HIV-1 | |
| Humans | |
| Immunization, Passive | |
| Vaccines, DNA |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38453885 | B cell memory: from generation to reactivation: a multipronged defense wall against pathogens. | Cell Death Discov | 2024 | https://conductscience.org/library/papers/38453885 | PubMed |
| 36050451 | Adeno-associated virus mediated expression of monoclonal antibody MR191 protects mice against Marburg virus and provides long-term expression in sheep. | Gene Ther | 2025 | https://conductscience.org/library/papers/36050451 | PubMed |
| 35664703 | Lipid nanoparticle delivery of unmodified mRNAs encoding multiple monoclonal antibodies targeting poxviruses in rabbits. | Mol Ther Nucleic Acids | 2022 | https://conductscience.org/library/papers/35664703 | PubMed |
| 31836872 | B cell memory: building two walls of protection against pathogens. | Nat Rev Immunol | 2020 | https://conductscience.org/library/papers/31836872 | PubMed |
| 31376325 | Biosimilar Gene Therapy: Investigational Assessment of Secukinumab Gene Therapy. | Cell J | 2020 | https://conductscience.org/library/papers/31376325 | PubMed |
| 30334070 | mRNA as novel technology for passive immunotherapy. | Cell Mol Life Sci | 2019 | https://conductscience.org/library/papers/30334070 | PubMed |
| 28592330 | State of play and clinical prospects of antibody gene transfer. | J Transl Med | 2017 | https://conductscience.org/library/papers/28592330 | PubMed |
| 28251988 | Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge. | Nat Commun | 2017 | https://conductscience.org/library/papers/28251988 | PubMed |
| 27413636 | Virus wars: using one virus to block the spread of another. | PeerJ | 2016 | https://conductscience.org/library/papers/27413636 | PubMed |
| 26650966 | Recombinant Adeno-Associated Virus Vector Genomes Take the Form of Long-Lived, Transcriptionally Competent Episomes in Human Muscle. | Hum Gene Ther | 2016 | https://conductscience.org/library/papers/26650966 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25757620
GET https://conductscience.org/api/papers/v1/25757620/authors